Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hartmut H-J Schmidt

Showing results (41-50 of 76) with videos related to

Pageof 8
Sort By:
Medizinische Klinik (Munich, Germany : 1983)|October 14, 2006
[Interdisciplinary guidelines for diagnosis and therapy of extracerebral amyloidosis: issued by the German Society of Amyloid Diseases e. V. (www.amyloid.de)]Christoph Röcken, Jutta Ernst, Ernst Hund, et al.
Emerging Microbes & Infections|August 31, 2023
Enhanced monitoring and detection of recent genotype 3 hepatitis E virus infection through urine antigen testingYannick Stahl, Iyad Kabar, Hauke Heinzow, et al.
The Journal of Clinical Endocrinology and Metabolism|March 16, 2007
Peroxisome proliferator-activated receptor-gamma C190S mutation causes partial lipodystrophyAngelika Lüdtke, Janine Buettner, Wei Wu, et al.
International Journal of Molecular Sciences|September 10, 2021
In Vitro and In Vivo Effects of SerpinA1 on the Modulation of Transthyretin ProteolysisFilipa Bezerra, Christoph Niemietz, Hartmut H J Schmidt, et al.
Journal of Hepatology|December 20, 2005
Treatment with daily consensus interferon (CIFN) plus ribavirin in non-responder patients with chronic hepatitis C: a randomized open-label pilot studyMarkus Cornberg, Johannes Hadem, Eva Herrmann, et al.
Journal of Clinical Pharmacology|January 25, 2006
Fingolimod (FTY720) in severe hepatic impairment: pharmacokinetics and relationship to markers of liver functionJohn M Kovarik, Robert L Schmouder, Stefan Hartmann, et al.
Experimental Cell Research|August 10, 2020
SERPINA1 modulates expression of amyloidogenic transthyretinChristoph Niemietz, Filipa Bezerra, Maria Rosário Almeida, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 5, 2011
Role of angiotensin-1 receptor blockade in cirrhotic liver resectionRalf Bahde, Linus Kebschull, Sandra Stöppeler, et al.
Annals of Hepatology|June 17, 2011
Course of a HBsAg positive liver transplantation in a hepatitis B and D virus coinfected recipientRalf Bahde, Jens P Hölzen, Heiner H Wolters, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 15, 2013
Evaluation of domino liver transplantations in GermanyFabian Johannes Bolte, Hartmut H-J Schmidt, Thomas Becker, et al.
Pageof 8

Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Medizinische Klinik (Munich, Germany : 1983)|October 14, 2006
[Interdisciplinary guidelines for diagnosis and therapy of extracerebral amyloidosis: issued by the German Society of Amyloid Diseases e. V. (www.amyloid.de)]Christoph Röcken, Jutta Ernst, Ernst Hund, et al.
Emerging Microbes & Infections|August 31, 2023
Enhanced monitoring and detection of recent genotype 3 hepatitis E virus infection through urine antigen testingYannick Stahl, Iyad Kabar, Hauke Heinzow, et al.
The Journal of Clinical Endocrinology and Metabolism|March 16, 2007
Peroxisome proliferator-activated receptor-gamma C190S mutation causes partial lipodystrophyAngelika Lüdtke, Janine Buettner, Wei Wu, et al.
International Journal of Molecular Sciences|September 10, 2021
In Vitro and In Vivo Effects of SerpinA1 on the Modulation of Transthyretin ProteolysisFilipa Bezerra, Christoph Niemietz, Hartmut H J Schmidt, et al.
Journal of Hepatology|December 20, 2005
Treatment with daily consensus interferon (CIFN) plus ribavirin in non-responder patients with chronic hepatitis C: a randomized open-label pilot studyMarkus Cornberg, Johannes Hadem, Eva Herrmann, et al.
Journal of Clinical Pharmacology|January 25, 2006
Fingolimod (FTY720) in severe hepatic impairment: pharmacokinetics and relationship to markers of liver functionJohn M Kovarik, Robert L Schmouder, Stefan Hartmann, et al.
Experimental Cell Research|August 10, 2020
SERPINA1 modulates expression of amyloidogenic transthyretinChristoph Niemietz, Filipa Bezerra, Maria Rosário Almeida, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 5, 2011
Role of angiotensin-1 receptor blockade in cirrhotic liver resectionRalf Bahde, Linus Kebschull, Sandra Stöppeler, et al.
Annals of Hepatology|June 17, 2011
Course of a HBsAg positive liver transplantation in a hepatitis B and D virus coinfected recipientRalf Bahde, Jens P Hölzen, Heiner H Wolters, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 15, 2013
Evaluation of domino liver transplantations in GermanyFabian Johannes Bolte, Hartmut H-J Schmidt, Thomas Becker, et al.
Pageof 8